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Abstract
One thousand thirty-eight normal glucose-tolerant and 1031 type 2 diabetic subjects selected from the Chennai Urban Rural
Epidemiology Study were genotyped using polymerase chain reaction-restriction fragment length polymorphism assay to investigate the
association of rs12255372(G/T) and rs7903146(C/T) polymorphisms of the transcription factor 7–like 2 (TCF7L2) gene with type 2 diabetes
mellitus in Asian Indians. The frequency of the “T” allele of both rs12255372(G/T) and rs7903146(C/T) polymorphisms was significantly
higher in diabetic subjects (23% and 33%) compared to that in normal glucose-tolerant subjects (19% and 28%; P = .001 and P = .0001,
respectively). Logistic regression analysis of the rs12255372(G/T) polymorphism showed that the odds ratio (adjusted for age, sex, and body
mass index) was 1.56 (95% confidence interval [CI], 1.03-2.37; P = .034) for the TT genotype and 1.29 (95% CI, 1.06-1.58; P = .011) for the
TG genotype when compared with the GG genotype. Adjusted odds ratios for the TT and TC genotypes of the rs7903146(C/T)
polymorphism were found to be 1.50 (95% CI, 1.08-2.08; P = .013) and 1.44 (95% CI, 1.18-1.76; P = .0003), respectively, compared with
the CC genotype. Normal glucose-tolerant subjects with the TT genotype of rs12255372(G/T) had significantly higher 2-hour plasma glucose
levels (mean ± SD, 6.1 ± 1.4 mmol/L) than those with the GG genotype (5.6 ± 1.0 mmol/L, P = .011). Normal glucose-tolerant subjects with
the TT genotype of rs7903146(C/T) polymorphism had significantly higher 2-hour plasma glucose levels (mean ± SD, 6.0 ± 1.3 mmol/L)
than those with the CC genotype (5.6 ± 1.0 mmol/L, P = .004). In conclusion, the T allele of the rs12255372(G/T) and rs7903146(C/T)
polymorphisms of TCF7L2 gene confer susceptibility to type 2 diabetes mellitus in Asian Indians.
© 2007 Elsevier Inc. All rights reserved.
1. Introduction
Although type 2 diabetes mellitus has a strong genetic
basis, until recently, most candidate genes for type 2
diabetes mellitus have shown only modest effects and the
associations have been inconsistent [1,2]. Reproducible
associations have been documented for the Pro12Ala
polymorphism in the peroxisome proliferator–activated
receptor (PPARG) gene and the E23K polymorphism in
the KCNJ11 gene [3,4]. Recently, Grant et al [5] reported
that the transcription factor 7–like 2 (TCF7L2) gene was
strongly associated with type 2 diabetes mellitus in
Icelandic subjects. TCF7L2 encodes a transcription factor
that plays a role in the Wnt signaling pathway, a key cell
developmental and growth regulatory mechanism. Florez
et al [6] reported that polymorphisms rs12255372 and
rs7903146 in the TCF7L2 gene were associated with an
increased risk of developing type 2 diabetes mellitus.
Subsequent studies confirmed association of these poly-
morphisms with type 2 diabetes mellitus in British [7], US
[8], Finnish [9], Amish [10], Scandinavian, Polish [11],
French [12], Dutch Breda [13], European whites, migrant
Asian Indian, Afro-Caribbean [14], northern Swedish [15],
and German [16] populations. The rs7903146 polymorph-
ism alone was found to be associated with type 2 diabetes
mellitus in Japanese population [17]. India has the largest
number of people with diabetes mellitus in the world [18].
Although the association of variants of the TCF7L2 gene
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and type 2 diabetes mellitus has been investigated in
several studies among white populations, there is only one
study from the western part of India [19]. Hence, we
examined the association of the 2 most strongly associated
single nucleotide polymorphisms (SNPs) of the TCF7L2
gene in almost all populations reported so far, the
rs12255372 and rs7903146 polymorphisms, with type 2
diabetes mellitus in an Asian Indian population in
southern India.
2. Methods
2.1. Study subjects
A total of 2069 subjects, 1031 type 2 diabetic subjects and
1038 normal glucose tolerant (NGT) subjects, were selected
from phase 2 and phase 3 of the Chennai Urban Rural
Epidemiology Study (CURES), respectively. The methodol-
ogy of the study has been published elsewhere [20]. Briefly,
26001 adult subjects (N20 years of age) were recruited in
phase 1 of the CURES using a systematic random sampling
method covering the whole Chennai city. This included 1529
“self-reported” diabetic subjects. In phase 2 of the CURES,
all self-reported diabetic subjects were invited to our center
for detailed studies, of whom 1382 responded (response rate,
90.4%). From the latter group, 1031 individuals with
diabetes, in whom the diagnosis was made by a physician,
who were on drug treatment for diabetes, who had fasting
plasma glucose of 7 mmol/L or higher (126 mg/dL), and in
whom genotyping could be performed were included in this
study. The control group of NGT subjects were chosen from
phase 3 of the CURES where every tenth subject from phase
1, excluding those with self-reported diabetes, underwent an
oral glucose tolerance test to rule out diabetes. From the
latter group, 1038 randomly selected subjects with NGT
defined as fasting plasma glucose of less than 5.6 mmol/L
(100 mg/dL) and 2-hour plasma glucose value of 7.8 mmol/L
or less (140 mg/dL) [21] were included in this study.
Anthropometric measurements including weight, height,
and waist were obtained using standardized techniques. The
body mass index (BMI) was calculated as the weight in
kilograms divided by the square of height in meters.
Biochemical analyses were done on a Hitachi-912 Auto-
analyzer (Hitachi, Mannheim, Germany) using kits supplied
by Roche Diagnostics (Mannheim, Germany). Fasting
plasma glucose (glucose oxidase−peroxidase [GOD-POD]
method), serum cholesterol (cholesterol oxidase−phenol4-
amino antipyrene peroxidase [CHOD-PAP] method), serum
triglycerides (glycerol phosphatase oxidase−phenol4-amino
antipyrene peroxidase [GPO-PAP] method), and high-
density lipoprotein cholesterol (direct method–polyethylene
glycol-pretreated enzymes) were measured. Low-density
lipoprotein cholesterol was calculated using the Friedewald
formula [22]. Glycated hemoglobin was estimated by high-
performance liquid chromatography using the Variant
machine (Bio-Rad, Hercules, CA).
2.2. Genotyping of rs12255372(G/T) and rs7903146(C/T)
polymorphisms
DNA was isolated from whole blood using the phenol-
chloroform method. The rs12255372 and rs7903146 poly-
morphisms were genotyped using the following primers:
forward, 5′-CTG GAAACTAAGGCG TGAGG-3′, reverse
5′-GGG TCG ATG TTG TTG AGC TT-3′ and forward 5′-
AAG AGA AGATTC CTT TTT AAATGG TG-3′, reverse
5′-CCT CAT ACG GCA ATT AAATTATAC A-3′ (Sigma,
Bangalore, India), respectively. A final reaction volume of
15μL of polymerase chain reaction contained 100 ng genomic
DNA, 5 pmol of each primer, polymerase chain reaction
buffer with 1 mmol/L of MgCl2, 100 μmol/L of each
deoxynucleotide triphospate (dNTP), and 0.5 U of Taq
polymerase (Gibco, Life Technologies, New York, NY).
Polymerase chain reaction was carried out on a Peltier
Thermal Cycler (PTC-200, MJ Research, Waltham, MA)
under the following conditions: 95°C for 5 minutes, followed
by 34 cycles of 95°C for 30 seconds, 54°C (for rs12255372)/
58°C (for rs7903146) for 30 seconds, 72°C for 30 seconds,
and a final extension of 72°C for 9 minutes. Restriction
fragment length polymorphism was carried out using Tsp509I
enzyme for the rs12255372(G/T) polymorphism and Hpy-
CH4III enzyme for the rs7903146(C/T) polymorphism. The
resulting products were electrophoresed on a 3% agarose gel.
To ensure that the genotyping was of adequate quality, we
performed random duplicates in 20% of the samples. The
assays were performed by a technician whowasmasked to the
phenotype, and there was 99% concordance in the genotyp-
ing. Furthermore, a few variants were confirmed by direct
sequencing with an ABI 310 genetic analyzer (Applied
Biosystems, Foster City, CA). Informed consent was obtained
from all the subjects who participated in this study, and the
study was approved by the institutional ethical committee.
2.3. Statistical analysis
SPSS Windows, version 10.0 (SPSS, Chicago, IL), was
used for statistical analysis. χ2 test was used to compare the
proportions of genotypes or alleles. One-way analysis of
variance was used to compare genotype class for continuous
variables. Data for continuous variables were expressed as
mean ± SD. Regression analysis of the quantitative traits and
the genotype class was adjusted for age and sex. Logistic
regression analysis with and without adjustment for age, sex,
and BMI was performed using diabetes as the dependent
variable and the genotypes as the independent variables. P
values of less than .05were considered statistically significant.
3. Results
3.1. Clinical and biochemical characteristics of the
study subjects
Table 1 shows the clinical and biochemical characteristics
of the study subjects. The diabetic subjects were older
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compared with the NGT subjects (49 ± 10 and 41 ± 11 years,
respectively; P b .0001). A comparison between diabetic
subjects and NGT subjects showed that the age- and sex-
adjusted mean ± SD of BMI (P b .0001), waist circumference
(P b .0001), total cholesterol (P b .0001), serum triglycerides
(P b .0001), and low-density lipoprotein cholesterol (P =
.001) were significantly higher in the diabetic subjects. All
the quantitative traits except for serum triglycerides had a
normal distribution; the latter values were therefore log
transformed before analysis.
3.2. Association of rs12255372(G/T) and rs7903146(C/T)
polymorphisms with type 2 diabetes mellitus
The genotypic distribution in both the NGTand the type 2
diabetic groups was in Hardy-Weinberg equilibrium. Table 2
shows the genotype and allele frequencies of the rs12255372
(G/T) and rs7903146(C/T) polymorphisms in the study
subjects. The frequency of the “T” allele of rs12255372(G/T)
was significantly higher in diabetic subjects (23%) compared
with that in the NGT subjects (19%) with the allelic odds
ratio being 1.30 (95% confidence interval [CI], 1.11-1.51;
P = .001). The frequency of the T allele of rs7903146(C/T)
polymorphism was significantly higher in diabetic subjects
(33%) compared with that in the NGTsubjects (28%) and the
allelic odds ratio was found to be 1.29 (95% CI, 1.13-1.48;
P = .0001). Logistic regression analysis of the rs12255372
(G/T) polymorphism showed that the odds ratio for diabetes
was 1.59 (95% CI, 1.08-2.36; P = .019) for the TT genotype
and 1.27 (95% CI, 1.05-1.53; P = .013) for the TG genotype
when compared with the GG genotype. Odds ratios adjusted
for potential confounders such as age, sex, and BMI also
showed that the TT (odds ratio [OR], 1.56; 95% CI, 1.03-
2.37; P = .034) and TG (OR, 1.29; 95% CI, 1.06-1.58; P =
.011) genotypes were associated with type 2 diabetes
mellitus. The unadjusted odds ratio for the TT and TC
genotypes of the rs7903146(C/T) polymorphism was found
to be 1.48 (95% CI, 1.10-2.01; P = .010) and 1.39 (95% CI,
1.16-1.67; P b .0001) when compared with the CC genotype.
Even after adjusting for age, sex, and BMI, subjects with the
TT and TC genotypes were more prone to diabetes (OR,
1.50; 95% CI, 1.08-2.08; P = .013 and 1.44; 95% CI, 1.18-
1.76; P = .0003, respectively).
3.3. Clinical and biochemical characteristics of the NGT
subjects stratified based on rs12255372(G/T) and
rs7903146(C/T) genotypes
Table 3 shows the comparison of the clinical and
biochemical characteristics of the NGT subjects stratified
based on rs12255372(G/T) and rs7903146(C/T) genotypes.
Normal glucose-tolerant subjects carrying the TT genotype
Table 2
Frequency of the rs12255372(G/T) and rs7903146(C/T) polymorphisms of TCF7L2 gene in the study subjects
Genotype NGT subjects
(n = 1038)
Type 2 diabetic
subjects (n = 1031)
Unadjusted OR (95% CI), P OR adjusted for age, sex,
and BMI (95% CI), P
rs12255372(G/T)
TT 46 (5%) 66 (6%) 1.59 (1.08-2.36), .019 1.56 (1.03-2.37), .034
TG 305 (29%) 348 (34%) 1.27 (1.05-1.53), .013 1.29 (1.06-1.58), .011
GG 687 (66%) 617 (60%) Reference Reference
Frequency of T allele 19% 23% 1.30 (1.11-1.51), .001 –
rs7903146(C/T)
TT 92 (9%) 114 (11%) 1.48 (1.10-2.01), .010 1.50 (1.08-2.08), .013
TC 391 (38%) 455 (44%) 1.39 (1.16-1.67), b.0001 1.44 (1.18-1.76), .0003
CC 555 (53%) 462 (45%) Reference Reference
Frequency of T allele 28% 33% 1.29 (1.13-1.48), .0001 –
Table 1
Clinical and biochemical characteristics of the study subjects
NGT subjects Type 2 diabetic subjects P
n (males/females) 1038 (426/612) 1031 (474/557) –
Age (y) 41 ± 11 49 ± 10 b.0001
BMI (kg/m2) 23.6 ± 4.6 25.1 ± 4.3 b.0001 a
Waist circumference (cm) 83.7 ± 11.6 90.4 ± 10.0 b.0001 a
Fasting plasma glucose (mmol/L) 4.6. ± 0.4 9.2 ± 4.0 b.0001 a
2-h postload plasma glucose (mmol/L) 5.6 ± 1.1 – –
Total cholesterol (mmol/L) 4.66 ± 0.90 5.15 ± 1.06 b.0001 a
HDL cholesterol (mmol/L) 1.11 ± 0.23 1.08 ± 0.23 .004 a
LDL cholesterol (mmol/L) 2.90 ± 0.77 3.34 ± 1.01 .001 a
Log-transformed serum triglycerides (mmol/L) 1.18 ± 0.01 1.72 ± 0.01 b.0001 a
Data are presented as mean ± SD. HDL indicates high-density lipoprotein; LDL, low-density lipoprotein.
a P value adjusted for age and sex.
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of rs12255372(G/T) polymorphism had significantly higher
2-hour plasma glucose levels (mean ± SD, 6.1 ± 1.4 mmol/L)
compared with the GG carriers (5.6 ± 1.0 mmol/L, P = .011
after adjusting for age and sex). The TTcarriers of rs7903146
(C/T) polymorphism also had significantly higher 2-hour
plasma glucose levels (mean ± SD, 6.0 ± 1.3 mmol/L)
compared with the CC carriers (5.6 ± 1.0 mmol/L, P = .004
after adjusting for age and sex). Although the same trend was
observed with respect to fasting plasma glucose and glycated
hemoglobin values in both the polymorphisms, statistical
significance was not achieved. None of the other biochem-
ical parameters including serum lipids showed any sig-
nificant differences among the 3 genotypes in either the NGT
or the diabetic subjects.
4. Discussion
The important finding of this study is that the
rs12255372 and rs7903146 SNPs are associated with type
2 diabetes mellitus in this Asian Indian population studied
in southern India. The SNPs rs12255372 and rs7903146
showed the strongest association with type 2 diabetes
mellitus in an Icelandic sample, and this association was
confirmed in white samples from Denmark and the United
States in the study by Grant et al [5]. All subsequent studies
conducted on various other populations [7-17,19] have
replicated the findings of Grant et al. Hence, we selected
these 2 SNPs for our study. Replication of this association
in Asian Indians who are highly prone to diabetes [18] is
of importance.
We observed a significant association between the T allele
of the rs12255372(G/T) and rs7903146(C/T) SNPs and type
2 diabetes mellitus in our study population. The frequency of
the T allele of rs12255372(G/T) was similar to the Finnish
[9] and substantially lower than the Icelandic [5] population.
Although the frequency of the T allele of rs7903146(C/T)
polymorphism in the NGT subjects was similar to the
frequency reported by Chandak et al [19], the T allele
frequency was lower in the type 2 diabetic subjects when
compared with that reported by Chandak et al [19] in their
diabetic population from the western part of India.
The significantly higher values in the 2-hour plasma
glucose levels in the TT homozygotes of both polymorph-
isms among NGT subjects (even after adjusting for the effect
for age and sex) further strengthen our finding that the T
allele of these variants is a risk allele for type 2 diabetes
mellitus. This is consistent with the studies by Chandak et al
[19] and Lehman et al [23] who have also reported
rs12255372 and rs7903146 variants to be associated with
increased 2-hour plasma glucose levels.
One of the limitations of the present study is that it has
not answered the functional consequences of these genetic
variants. The consistency of association evidenced by
various replication studies suggests that TCF7L2 gene
represents an important locus for genetic susceptibility to
type 2 diabetes mellitus, but the biological mechanism for
the association between the TCF7L2 gene and type 2
diabetes mellitus risk is still unclear. From the available
information, it can be speculated that the TCF7L2 gene has
a role in insulin secretion [24] and possibly adipose tissue
development. Furthermore, the genetic variants that have
been studied are present in the introns rather than in the
coding regions. However, this may still lead to functional
consequences in terms of protein stability and/or expres-
sion of alternatively spliced variants. In conclusion, our
study confirms the association of the rs12255372 and
rs7903146 polymorphisms of the TCF7L2 gene with type
2 diabetes mellitus in this Asian Indian population in
southern India.
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Table 3
Clinical and biochemical characteristics of the NGT subjects stratified based on rs12255372(G/T) and rs7903146(C/T) genotypes
Genotype rs12255372(G/T) rs7903146(C/T)
TT (n = 46) TG (n = 305) GG (n = 687) TT (n = 92) TC (n = 391) CC (n = 555)
BMI (kg/m2) 24.2 ± 4.8 23.7 ± 4.2 23.5 ± 4.7 24.3 ± 5.1 23.2 ± 4.4 23.7 ± 4.6
Waist circumference (cm) 84.6 ± 10 84.0 ± 10.9 83.6 ± 12 85.2 ± 10.9 82.9 ± 11.4 83.8 ± 11.8
Fasting plasma glucose (mmol/L) 4.7 ± 0.4 4.6 ± 0.3 4.6 ± 0.4 4.7 ± 0.5 4.7 ± 0.4 4.6 ± 0.4
2-h postload plasma glucose (mmol/L) 6.1 ± 1.4 ⁎ 5.6 ± 1.1 5.6 ± 1.0 6.0 ± 1.3 ⁎⁎ 5.7 ± 1.1 5.6 ± 1.0
Glycated hemoglobin (%) 5.7 ± 0.5 5.6 ± 0.4 5.5 ± 0.4 5.7 ± 0.5 5.6 ± 0.4 5.5 ± 0.4
Total cholesterol (mmol/L) 4.58 ± 0.77 4.63 ± 0.98 4.66 ± 0.88 4.54 ± 0.95 4.65 ± 0.89 4.67 ± 0.91
HDL cholesterol (mmol/L) 1.11 ± 0.25 1.11 ± 0.25 1.11 ± 0.23 1.08 ± 0.24 1.12 ± 0.26 1.12 ± 0.24
LDL cholesterol (mmol/L) 2.87 ± 0.62 2.87 ± 0.85 2.92 ± 0.75 2.85 ± 0.79 2.90 ± 0.78 2.94 ± 0.70
Log-transformed serum triglycerides (mmol/L) 1.13 ± 0.02 1.20 ± 0.01 1.17 ± 0.01 1.32 ± 0.02 1.19 ± 0.02 1.17 ± 0.01
Data are presented as mean ± SD.
⁎ P = .011 compared to GG (adjusted for age and sex).
⁎⁎ P = .004 compared to CC (adjusted for age and sex).
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